U.S. Food and Drug Administration
Protecting and Promoting Your Health
Office of New Drug Review Divisions
The Office of New Drugs (OND):
- Provides regulatory oversight during drug development.
- Makes decisions regarding marketing approval for new drugs.
- Provides guidance to regulated industry on clinical, scientific, and regulatory matters.
- OND is made up of six review offices (click the graphic for an enlarged PDF).
Click the picture of the OND Chart to enlarge it. Click NEXT to continue.